XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues    
Collaboration and licensing revenues, including $28,887 and $19,999 from related parties during the three months ended March 31, 2017 and 2016, respectively $ 33,065 $ 24,073
Product revenues 8,130 8,555
Service revenues 12,031 10,665
Other revenues 521 145
Total revenues 53,747 43,438
Operating Expenses    
Cost of products 9,006 9,562
Cost of services 6,804 5,672
Research and development 34,180 25,856
Selling, general and administrative 35,138 42,881
Total operating expenses 85,128 83,971
Operating loss (31,381) (40,533)
Other Income (Expense), Net    
Unrealized depreciation in fair value of equity securities and preferred stock (1,622) (22,331)
Interest expense (179) (265)
Interest and dividend income 4,624 610
Other income, net 595 561
Total other income (expense), net 3,418 (21,425)
Equity in net loss of affiliates (4,947) (5,643)
Loss before income taxes (32,910) (67,601)
Income tax benefit 533 2,281
Net loss (32,377) (65,320)
Net loss attributable to the noncontrolling interests 978 891
Net loss attributable to Intrexon $ (31,399) $ (64,429)
Net loss attributable to Intrexon per share, basic and diluted (in usd per share) $ (0.26) $ (0.55)
Weighted average shares outstanding, basic and diluted (in shares) 118,956,780 116,861,151